Anastasia van Leuven
Surgical · Las Vegas, NVNPI 1851531305
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,580 of the $6,380 with a category attached, or 87.5%. It is spread thinly across 32 manufacturers, the largest accounting for just 21.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,345 and has fallen 60.7% since, to $921 in 2025. Among surgical clinicians in NV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 300 payments — averaging $21.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Biohaven Pharmaceuticals, Inc.$977
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$813
- Scilex Pharmaceuticals Inc.$603
- Forte Bio-pharma LLC$473
- Pfizer$376
- plus $2K from 26 others
What the payments were for
- Consulting fees$80013%
- Food & beverage$5,58087%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 84 | $1,392 |
| Biohaven Pharmaceuticals, Inc. | 10 | $977 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 40 | $813 |
| Scilex Pharmaceuticals Inc. | 42 | $603 |
| Forte Bio-pharma LLC | 17 | $473 |
| Pfizer | 22 | $376 |
| Lundbeck LLC | 13 | $312 |
| Collegium Pharmaceutical, Inc. | 12 | $212 |
| Abbott | 5 | $150 |
| Nevro Corp. | 1 | $135 |
| IBSA Pharma Inc. | 7 | $126 |
| Redhill Biopharma Inc. | 5 | $93 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $92 |
| SPR Therapeutics, Inc | 3 | $56 |
| Axsome Therapeutics, Inc. | 3 | $52 |
| Biotronik NRO, Inc. | 2 | $51 |
| Arbor Pharmaceuticals, Inc. | 3 | $49 |
| Azurity Pharmaceuticals, Inc. | 3 | $47 |
| Eisai Inc. | 3 | $47 |
| Lilly USA, LLC | 3 | $40 |
| Almatica Pharma LLC | 2 | $39 |
| Protega Pharmaceutials Inc | 2 | $37 |
| Boston Scientific | 2 | $30 |
| Biodelivery Sciences International, Inc. | 2 | $29 |
| Averitas Pharma Inc. | 1 | $25 |
| Vertex | 1 | $24 |
| Medtronic | 1 | $18 |
| Curonix LLC | 1 | $18 |
| Saluda Medical Americas, Inc. | 1 | $18 |
| Nalu Medical, Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$800
- Omnia$135
How this compares
$6,380 in reported general payments places this provider in the 90th percentile of 91 surgical providers in Nevada.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 339 | $61,340 |
| RelistorMethylnaltrexone Bromide | 15 | $36,940 |
| OxycontinOxycodone Hcl | 26 | $27,638 |
| Xtampza ErOxycodone Myristate | 31 | $19,143 |
| Aimovig AutoinjectorErenumab-Aooe | 25 | $17,900 |
| MovantikNaloxegol Oxalate | 36 | $14,494 |
| Oxycodone Hcl | 516 | $13,316 |
| QuliptaAtogepant | 11 | $11,312 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 288 | $8,584 |
| Morphine Sulfate ErMorphine Sulfate | 304 | $8,250 |
| ZtlidoLidocaine | 14 | $6,338 |
| Diclofenac Sodium | 35 | $6,280 |
| Naloxone Hcl | 71 | $5,105 |
| Pregabalin | 170 | $4,853 |
| Gabapentin | 296 | $3,603 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $813 | $36,94015 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er | $212 | $19,14331 claims |
| Redhill Biopharma Inc.Movantik | $93 | $14,49436 claims |
| AbbVieQulipta | $1,392 | $11,31211 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $603 | $6,33814 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 91 surgical providers in Nevada.
Other surgical in Las Vegas
- Heather RohrerLas Vegas$253K
- Andrea EghterafiLas Vegas$11K
- Kasie PalmerLas Vegas$8K
- Jeffrey HaynesLas Vegas$8K
- Darin DutsonLas Vegas$8K
- Edmund Afrim-AntwiLas Vegas$4K
- Milan PatelLas Vegas$4K
- Heather TaLas Vegas$3K
- Sherry HallLas Vegas$3K
- Angelie TengLas Vegas$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.